세계의 eHealth 시장 : 업계 동향과 예측(-2029년)

Global eHealth market is projected to register a CAGR of 24.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029.

Market Segmentation:

Global eHealth Market, By Offering (Solutions and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and Small and Medium Enterprises), Functionality (Content Management System, Group Messaging, Dashboard, Video Sessions, Social Support, and Others), Technology (Internet of Things (IoT), Chatbots, Artificial Intelligence, Block Chain and Big Data Analytics, and Others), End User (Healthcare Providers, Payers, Healthcare Consumers, Pharmacies, and Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, and Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific, Brazil, Argentina, and Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Some of the significant factors contributing to the growth of the eHealth market are:

Increasing demand for telehealth

Increasing government initiatives supporting the use of eHealth services and solutions

Rising technological advancements in eHealth

Market Players:

The key market players in the global eHealth market are listed below:

Allscripts Healthcare, LLC

Apple Inc.

Athena health

BioTelemetry, a Philips company

Boston Scientific Corporation

Cantata Health Solutions

Cisco Systems, Inc.

Doximity, Inc.

eHealth Technologies

Epic Systems Corporation

General Electric Company

IBM Corporation

iHealth Labs Inc.

Implantica

Kazaam INC.

KoninklijkePhilips N.V.

LIFEN

McKesson Corporation

Medisafe

Medtronic

Optum Inc.

Oracle

SATMED

Siemens Healthcare Gmbh

Teladoc Health, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 15

• 1.1 OBJECTIVES OF THE STUDY 15
• 1.2 MARKET DEFINITION 15
• 1.3 OVERVIEW OF THE GLOBAL EHEALTH MARKET 15
• 1.4 LIMITATIONS 16
• 1.5 MARKETS COVERED 17

2 MARKET SEGMENTATION 19

• 2.1 MARKETS COVERED 19
• 2.2 GEOGRAPHICAL SCOPE 20
• 2.3 YEARS CONSIDERED FOR THE STUDY 20
• 2.4 CURRENCY AND PRICING 20
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 21
• 2.6 MULTIVARIATE MODELLING 24
• 2.7 TYPE LIFELINE CURVE 24
• 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
• 2.9 DBMR MARKET POSITION GRID 26
• 2.10 MARKET APPLICATION COVERAGE GRID 27
• 2.11 VENDOR SHARE ANALYSIS 28
• 2.12 SECONDARY SOURCES 29
• 2.13 ASSUMPTIONS 29

3 EXECUTIVE SUMMARY 30

4 PREMIUM INSIGHTS 32

• 4.1 PORTER'S FIVE FORCES MODEL 35
• 4.2 DIGITAL FRONT DOOR SOLUTIONS & BENEFITS OF GLOBAL EHEALTH MARKET 36
• 4.3 ECOSYSTEM MODEL FOR EHEALTHCARE SYSTEM OF GLOBAL EHEALTH MARKET 37
• 4.4 EHEALTH DIGITAL INNOVATION AND PREVENTION OF GLOBAL EHEALTH MARKET 38
• 4.5 OPEN DATA PLATFORMS IN EHEALTH OF GLOBAL EHEALTH MARKET 39
• 4.6 TRENDS TO SHAPE THE EHEALTH INDUSTRY OF GLOBAL EHEALTH MARKET 40
  • 4.6.1 APP ON PRESCRIPTION 40
  • 4.6.2 TELEMEDICINE 40
  • 4.6.3 SMART MEDICAL THINGS 40
  • 4.6.4 DATA PROTECTION 41
  • 4.6.5 MEDICAL DEEP LEARNING 41
• 4.7 VALUE CHAIN OF GLOBAL EHEALTH MARKET 42
• 4.8 GLOBAL EHEALTH MARKET: REGULATIONS 43

5 MARKET OVERVIEW 45

• 5.1 DRIVERS 47
  • 5.1.1 INCREASE IN THE PREVALENCE OF CHRONIC DISEASES 47
  • 5.1.2 RISE IN THE TECHNOLOGICAL ADVANCEMENTS IN EHEALTH 48
  • 5.1.3 INCREASE IN THE DEMAND FOR TELEHEALTH 49
  • 5.1.4 INCREASING GOVERNMENT INITIATIVES SUPPORTING THE USE OF EHEALTH SERVICES AND SOLUTIONS 49
• 5.2 RESTRAINTS 50
  • 5.2.1 STRICT REGULATORY FRAMEWORK 50
  • 5.2.2 INCREASE UNMET HOME CARE NEEDS 50
• 5.3 OPPORTUNITIES 51
  • 5.3.1 RISING USE OF EHEALTH SOLUTIONS IN OUTPATIENT CARE FACILITIES 51
  • 5.3.2 PROVIDES QUICK ONLINE RESULTS AND QUICK HEALTHCARE CONSULTANCY 52
  • 5.3.3 STRATEGIC INITIATIVES AND DEVELOPMENTS BY KEY PLAYERS 53
• 5.4 CHALLENGES 54
  • 5.4.1 LACK OF SKILLED PROFESSIONALS TO HANDLE E-HEALTH TECHNOLOGY 54
  • 5.4.2 PATIENTS DATA SECURITY IN E-HEALTH 54

6 GLOBAL EHEALTH MARKET, BY OFFERING 55

• 6.1 OVERVIEW 56
• 6.2 SERVICES 59
  • 6.2.1 REMOTE MONITORING SERVICES 59
  • 6.2.2 DATABASE MANAGEMENT SERVICES 59
  • 6.2.3 DIAGNOSIS AND CONSULTATION SERVICES 59
  • 6.2.4 HEALTHCARE SYSTEM STRENGTHENING SERVICES 60
  • 6.2.5 TREATMENT SERVICES 60
• 6.3 SOLUTIONS 60
  • 6.3.1 ELECTRONIC HEALTH RECORDS (HER) / ELECTRONIC MEDICAL RECORDS (EMR) 61
  • 6.3.2 MEDICAL APPS 61
  • 6.3.3 PERSONAL HEALTH RECORD AND PATIENT PORTALS 61
  • 6.3.4 TELEHEALTH SOLUTIONS 61
  • 6.3.5 CHRONIC CARE MANAGEMENT APPS 61
  • 6.3.6 PHARMACY INFORMATION SYSTEMS 62
  • 6.3.7 CLINICAL DECISION SUPPORT SYSTEMS 62
  • 6.3.8 LABORATORY INFORMATION SYSTEMS RIGID (RIS) 62
  • 6.3.9 HEALTHCARE INFORMATION EXCHANGE 62
  • 6.3.10 RADIOLOGY INFORMATION SYSTEMS (RIS) E-PRESCRIBING SOLUTIONS 62
  • 6.3.11 CARDIOVASCULAR INFORMATION SYSTEMS 62
• 6.4 OTHERS 62

7 GLOBAL EHEALTH MARKET, BY DEPLOYMENT 63

• 7.1 OVERVIEW 64
• 7.2 CLOUD 67
  • 7.2.1 PRIVATE CLOUD 67
  • 7.2.2 PUBLIC CLOUD 67
  • 7.2.3 HYBRID CLOUD 67
• 7.3 ON-PREMISES 68

8 GLOBAL EHEALTH MARKET, BY ENTERPRISE SIZE 69

• 8.1 OVERVIEW 70
• 8.2 LARGE ENTERPRISES 73
• 8.3 SMALL AND MEDIUM ENTERPRISES 73

9 GLOBAL EHEALTH MARKET, BY FUNCTIONALITY 74

• 9.1 OVERVIEW 75
• 9.2 VIDEO SESSIONS 78
• 9.3 CONTENT MANAGEMENT SYSTEMS (CMS) 78
• 9.4 DASHBOARD 79
• 9.5 GROUP MESSAGING 79
• 9.6 SOCIAL SUPPORT 80
• 9.7 OTHERS 80

10 GLOBAL EHEALTH MARKET, BY TECHNOLOGY 81

• 10.1 OVERVIEW 82
• 10.2 CHATBOTS 85
• 10.3 ARTIFICIAL INTELLIGENCE 85
• 10.4 INTERNET OF THINGS (IOT) 86
• 10.5 BLOCK CHAIN AND BIG DATA ANALYTICS 86
• 10.6 OTHERS 87

11 GLOBAL EHEALTH MARKET, BY END USER 88

• 11.1 OVERVIEW 89
• 11.2 HEALTHCARE PROVIDERS 92
• 11.3 HEALTHCARE PROVIDERS, BY TYPE 92
  • 11.3.1 HOSPITALS 92
  • 11.3.2 AMBULATORY CARE CENTERS 92
  • 11.3.3 HOME HEALTHCARE AGENCIES, NURSING HOMES, AND ASSISTED LIVING CENTRES 93
• 11.4 HEALTHCARE PROVIDERS, BY ENTERPRISE SIZE 93
  • 11.4.1 LARGE ENTERPRISES 93
  • 11.4.2 SMALL AND MEDIUM ENTERPRISES 93
• 11.5 PHARMACIES 93
  • 11.5.1 LARGE ENTERPRISES 94
  • 11.5.2 SMALL AND MEDIUM ENTERPRISES 94
• 11.6 PAYERS 94
  • 11.6.1 LARGE ENTERPRISES 95
  • 11.6.2 SMALL AND MEDIUM ENTERPRISES 95
• 11.7 HEALTHCARE CONSUMERS 95
  • 11.7.1 LARGE ENTERPRISES 96
  • 11.7.2 SMALL AND MEDIUM ENTERPRISES 96
• 11.8 OTHERS 96

12 GLOBAL EHEALTH MARKET, BY REGION 97

• 12.1 OVERVIEW 98
• 12.2 ASIA-PACIFIC 104
  • 12.2.1 VIETNAM 114

13 GLOBAL EHEALTH MARKET: COMPANY LANDSCAPE 119

• 13.1 COMPANY SHARE ANALYSIS: GLOBAL 119
• 13.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 120

14 SWOT ANALYSIS 121

15 COMPANY PROFILE 122

• 15.1 IBM CORPORATION (2021) 122
  • 15.1.1 COMPANY SNAPSHOT 122
  • 15.1.2 REVENUE ANALYSIS 122
  • 15.1.3 COMPANY SHARE ANALYSIS 123
  • 15.1.4 PRODUCT PORTFOLIO 123
  • 15.1.5 RECENT DEVELOPMENT 123
• 15.2 APPLE INC. 124
  • 15.2.1 COMPANY SNAPSHOT 124
  • 15.2.2 REVENUE ANALYSIS 124
  • 15.2.3 COMPANY SHARE ANALYSIS 125
  • 15.2.4 PRODUCT PORTFOLIO 125
  • 15.2.5 RECENT DEVELOPMENTS 125
• 15.3 MCKESSON CORPORATION 126
  • 15.3.1 COMPANY SNAPSHOT 126
  • 15.3.2 REVENUE ANALYSIS 126
  • 15.3.3 COMPANY SHARE ANALYSIS 127
  • 15.3.4 PRODUCT PORTFOLIO 127
  • 15.3.5 RECENT DEVELOPMENT 127
• 15.4 GENERAL ELECTRIC COMPANY (2021) 128
  • 15.4.1 COMPANY SNAPSHOT 128
  • 15.4.2 REVENUE ANALYSIS 128
  • 15.4.3 COMPANY SHARE ANALYSIS 129
  • 15.4.4 PRODUCT PORTFOLIO 129
  • 15.4.5 RECENT DEVELOPMENT 129
• 15.5 TELADOC HEALTH, INC (2021) 131
  • 15.5.1 COMPANY SNAPSHOT 131
  • 15.5.2 REVENUE ANALYSIS 131
  • 15.5.3 COMPANY SHARE ANALYSIS 132
  • 15.5.4 PRODUCT PORTFOLIO 132
  • 15.5.5 RECENT DEVELOPMENT 132
• 15.6 ALLSCRIPTS HEALTHCARE, LLC (2021) 133
  • 15.6.1 COMPANY SNAPSHOT 133
  • 15.6.2 REVENUE ANALYSIS 133
  • 15.6.3 PRODUCT PORTFOLIO 134
  • 15.6.4 RECENT DEVELOPMENT 134
• 15.7 ATHENAHEALTH (2021) 135
  • 15.7.1 COMPANY SNAPSHOT 135
  • 15.7.2 PRODUCT PORTFOLIO 135
  • 15.7.3 RECENT DEVELOPMENT 135
• 15.8 BIOTELEMETRY, A PHILIPS COMPANY (2021) 136
  • 15.8.1 COMPANY SNAPSHOT 136
  • 15.8.2 PRODUCT PORTFOLIO 136
  • 15.8.3 RECENT DEVELOPMENT 136
• 15.9 BOSTON SCIENTIFIC CORPORATION (2021) 137
  • 15.9.1 COMPANY SNAPSHOT 137
  • 15.9.2 REVENUE ANALYSIS 138
  • 15.9.3 PRODUCT PORTFOLIO 138
  • 15.9.4 RECENT DEVELOPMENT 138
• 15.10 CANTATA HEALTH SOLUTIONS (2021) 139
  • 15.10.1 COMPANY SNAPSHOT 139
  • 15.10.2 PRODUCT PORTFOLIO 139
  • 15.10.3 RECENT DEVELOPMENT 139
• 15.11 CISCO SYSTEMS 140
  • 15.11.1 COMPANY SNAPSHOT 140
  • 15.11.2 REVENUE ANALYSIS 141
  • 15.11.3 PRODUCT PORTFOLIO 141
  • 15.11.4 RECENT DEVELOPMENT 141
• 15.12 DOXIMITY, INC. (2021) 142
  • 15.12.1 COMPANY SNAPSHOT 142
  • 15.12.2 REVENUE ANALYSIS 142
  • 15.12.3 PRODUCT PORTFOLIO 143
  • 15.12.4 RECENT DEVELOPMENT 143
• 15.13 EHEALTH TECHNOLOGIES 144
  • 15.13.1 COMPANY SNAPSHOT 144
  • 15.13.2 PRODUCT PORTFOLIO 144
  • 15.13.3 RECENT DEVELOPMENT 144
• 15.14 EPIC SYSTEMS CORPORATION (2021) 145
  • 15.14.1 COMPANY SNAPSHOT 145
  • 15.14.2 PRODUCT PORTFOLIO 145
  • 15.14.3 RECENT DEVELOPMENT 145
• 15.15 IHEALTH LABS INC (2021) 146
  • 15.15.1 COMPANY SNAPSHOT 146
  • 15.15.2 PRODUCT PORTFOLIO 146
  • 15.15.3 RECENT DEVELOPMENT 146
• 15.16 IMPLANTICA (2021) 147
  • 15.16.1 COMPANY SNAPSHOT 147
  • 15.16.2 REVENUE ANALYSIS 147
  • 15.16.3 PRODUCT PORTFOLIO 148
  • 15.16.4 RECENT DEVELOPMENT 148
• 15.17 KAZAAM INC. 149
  • 15.17.1 COMPANY SNAPSHOT 149
  • 15.17.2 PRODUCT PORTFOLIO 149
  • 15.17.3 RECENT DEVELOPMENTS 149
• 15.18 KONINKLIJKE PHILIPS N.V. (2021) 150
  • 15.18.1 COMPANY SNAPSHOT 150
  • 15.18.2 REVENUE ANALYSIS 150
  • 15.18.3 PRODUCT PORTFOLIO 151
  • 15.18.4 RECENT DEVELOPMENTS 151
• 15.19 LIFEN 153
  • 15.19.1 COMPANY SNAPSHOT 153
  • 15.19.2 PRODUCT PORTFOLIO 153
  • 15.19.3 RECENT DEVELOPMENTS 153
• 15.20 MEDISAFE (2021) 154
  • 15.20.1 COMPANY SNAPSHOT 154
  • 15.20.2 PRODUCT PORTFOLIO 154
  • 15.20.3 RECENT DEVELOPMENT 154
• 15.21 MEDTRONIC (2021) 155
  • 15.21.1 COMPANY SNAPSHOT 155
  • 15.21.2 REVENUE ANALYSIS 155
  • 15.21.3 PRODUCT PORTFOLIO 156
  • 15.21.4 RECENT DEVELOPMENT 156
• 15.22 OPTUM INC. 157
  • 15.22.1 COMPANY SNAPSHOT 157
  • 15.22.2 PRODUCT PORTFOLIO 157
  • 15.22.3 RECENT DEVELOPMENT 157
• 15.23 ORACLE 158
  • 15.23.1 COMPANY SNAPSHOT 158
  • 15.23.2 REVENUE ANALYSIS 158
  • 15.23.3 PRODUCT PORTFOLIO 159
  • 15.23.4 RECENT DEVELOPMENTS 159
• 15.24 SATMED 160
  • 15.24.1 COMPANY SNAPSHOT 160
  • 15.24.2 PRODUCT PORTFOLIO 160
  • 15.24.3 RECENT DEVELOPMENTS 160
• 15.25 SIEMENS HEALTHCARE GMBH 161
  • 15.25.1 COMPANY SNAPSHOT 161
  • 15.25.2 REVENUE ANALYSIS 161
  • 15.25.3 PRODUCT PORTFOLIO 162
  • 15.25.4 RECENT DEVELOPMENTS 162

16 QUESTIONNAIRE 163

17 RELATED REPORTS 166